504 related articles for article (PubMed ID: 7976403)
1. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
2. D-myo-inositol 1,2,6-trisphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bed.
Donoso MV; Boric M; Prado M; Fournier A; St Pierre S; Edvinsson L; Huidobro-Toro JP
Eur J Pharmacol; 1993 Aug; 240(1):93-7. PubMed ID: 8405129
[TBL] [Abstract][Full Text] [Related]
3. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L
J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501
[TBL] [Abstract][Full Text] [Related]
4. Augmented sensory-motor vasodilatation of the rat mesenteric arterial bed after chronic infusion of the P1-purinoceptor antagonist, DPSPX.
Relevic V; Rubino A; Burnstock G
Br J Pharmacol; 1996 Aug; 118(7):1675-80. PubMed ID: 8842431
[TBL] [Abstract][Full Text] [Related]
5. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Donoso MV; Steiner M; Huidobro-Toro JP
J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
[TBL] [Abstract][Full Text] [Related]
6. Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 Apr; 117(7):1463-70. PubMed ID: 8730740
[TBL] [Abstract][Full Text] [Related]
7. Prejunctional modulation of sensory-motor nerve-mediated vasodilatation of the rat mesenteric arterial bed by opioid peptides.
Ralevic V; Rubino A; Burnstock G
J Pharmacol Exp Ther; 1994 Feb; 268(2):772-8. PubMed ID: 8113989
[TBL] [Abstract][Full Text] [Related]
8. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
9. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats.
Ralevic V; Belai A; Burnstock G
Br J Pharmacol; 1993 Nov; 110(3):1105-11. PubMed ID: 8298799
[TBL] [Abstract][Full Text] [Related]
10. Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bed.
Ralevic V
Br J Pharmacol; 1995 Apr; 114(8):1541-8. PubMed ID: 7599921
[TBL] [Abstract][Full Text] [Related]
11. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
Bell D; Millar BC; McDermott BJ
Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.
Prieto D; Buus CL; Mulvany MJ; Nilsson H
Br J Pharmacol; 2000 Apr; 129(8):1689-99. PubMed ID: 10780975
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
14. Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y.
Chen H; Bischoff A; Schäfers RF; Wambach G; Philipp T; Michel MC
J Auton Pharmacol; 1997 Jun; 17(3):137-46. PubMed ID: 9278773
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
Adamsson M; Fallgren B; Edvinsson L
Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues.
Walsh DA; Mapp PI; Polak JM; Blake DR
J Pharmacol Exp Ther; 1995 Apr; 273(1):461-9. PubMed ID: 7714802
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Sun X; Edvinsson L; Hedner T
J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175
[TBL] [Abstract][Full Text] [Related]
18. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
[TBL] [Abstract][Full Text] [Related]
19. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
[TBL] [Abstract][Full Text] [Related]
20. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
Sun XY; Edvinsson L; Hedner T
J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
